Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rystiggo
Pharma
J&J's Imaavy comes up short in rheumatoid arthritis study
Flying high after an FDA approval to treat gMG, J&J's Imaavy has come up short as part of a combination therapy in a rheumatoid arthritis trial.
Kevin Dunleavy
Aug 29, 2025 10:56am
J&J's Imaavy wins FDA green light in myasthenia gravis
Apr 30, 2025 10:51am
After busy 2023, UCB expects approval spree to keep rolling
Feb 28, 2024 11:02am
With Zilbrysq, UCB gains its second FDA nod in gMG in 4 months
Oct 18, 2023 1:08pm
